Skip to main content

Table 6 Clinical outcomes

From: A randomized trial of supplemental parenteral nutrition in underweight and overweight critically ill patients: the TOP-UP pilot trial

Variable

EN only (n = 73)

SPN + EN (OLIMEL) (n = 52)

p value

Length of ventilation, days

8.3 (3.8–13.3)

6.5 (3.9–14.1)

0.78

ICU mortality

  

0.51

 Yes

13 (17.8%)

7 (13.5%)

 

 No, patient discharged

60 (82.2%)

45 (86.5%)

Length of stay in ICU among survivors, days

12.6 (8.1–18.7)

12.8 (7.9–17.8)

0.80

Hospital mortality

  

0.29

 Yes

17 (23.3%)

8 (15.4%)

 

 No, patient discharged

56 (76.7%)

43 (82.7%)

 No, patient still in hospital at 6 months

0 (0.0%)

1 (1.9%)

Length of stay in hospital among survivors, days

24.0 (16.6–38.9)

23.5 (17.5–34.7)

0.83

Time to discharge alive from hospital

33.0 (20.2, und)

32.5 (21.1, und)

0.87

Kaplan-Meier 6-month mortality estimatea

27.5%

29.5%

0.86

  1. Data reported as median (Q1–Q3) or n (%). The Mann-Whitney U test was used for continuous variables, and the chi-square test was used for categorical variables. Survival analysis was used for comparison of time to discharge alive from hospital
  2. Abbreviations: EN enteral nutrition, ICU intensive care unit, SPN supplemental parenteral nutrition, und undefined due to <75% reaching upper quartile
  3. aThe Kaplan-Meier estimate censors patients at the last known date alive. Altogether, 19 deaths were observed in the EN-alone arm, compared with 14 deaths in the SPN + EN arm. The median follow-up time among patients where death was not observed was 175 days in the EN-alone arm and 167 days in the SPN + PN arm